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Abstract
Purpose—The criteria for autism spectrum disorder (ASD) were revised in the fifth edition of 
the Diagnostic and Statistical Manual of Mental Disorders (DSM). The objective of this study was 
to compare the sensitivity and specificity of DSM-IV-Text Revision (DSM-IV-TR) and DSM-5 
definitions of ASD in a community-based sample of preschool children.
Methods—Children between 2 and 5 years of age were enrolled in the Study to Explore Early 
Development-Phase 2 (SEED2) and received a comprehensive developmental evaluation. The 
clinician(s) who evaluated the child completed two diagnostic checklists that indicated the 
presence and severity of DSM-IV-TR and DSM-5 criteria. Definitions for DSM-5 ASD, DSM-IV-
TR autistic disorder, and DSM-IV-TR Pervasive Developmental Disorder Not Otherwise Specified 
(PDD-NOS) were created from the diagnostic checklists.
Results—773 children met SEED2 criteria for ASD and 288 met criteria for another 
developmental disorder (DD). Agreement between DSM-5 and DSM-IV-TR definitions of ASD 
were good for autistic disorder (0.78) and moderate for PDD-NOS (0.57 and 0.59). Children who 
met DSM-IV-TR autistic disorder but not DSM-5 ASD (n = 71) were more likely to have mild 
ASD symptoms, or symptoms accounted for by another disorder. Children who met PDD-NOS but 
not DSM-5 ASD (n = 66), or vice versa (n = 120) were less likely to have intellectual disability 
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and more likely to be female. Sensitivity and specificity were best balanced with DSM-5 ASD 
criteria (0.95 and 0.78, respectively).
Conclusions—The DSM-5 definition of ASD maximizes diagnostic sensitivity and specificity 
in the SEED2 sample. These findings support the DSM-5 conceptualization of ASD in preschool 
children.
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Autism; Autism spectrum disorder; Diagnostic and Statistical Manual of Mental Disorders (DSM); 
Diagnostic criteria
Introduction
Autism spectrum disorder (ASD) is a developmental disability that affects social 
communication and behavior development and is typically recognized in the first few years 
of life [1]. ASD is the fastest growing developmental disability and costs $236–262 billion 
per year in the USA [2]. More debilitating forms of ASD are associated with greater 
economic burden [2], parental stress [3], and more medical and behavior co-morbidities [4]. 
Early detection of ASD symptoms facilitates referral for early intervention services which 
are associated with improved developmental outcomes [5, 6]. The early detection of ASD is 
an important public health priority that may address immediate and long-term needs of 
children and families.
ASD is a behaviorally defined disorder that relies on child observation and parent report to 
differentiate from other childhood conditions [7]. The criteria used to diagnose ASD are 
outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM) published by 
the American Psychiatric Association (APA0). In DSM-IV-Text Revised (DSM-IV-TR), 
ASD included subtypes of autistic disorder, Asperger disorder, and Pervasive Developmental 
Disorder Not Otherwise Specified (PDD-NOS) [8]. A diagnosis of autistic disorder required 
the presence of at least six of 12 total symptoms from three domains (two social, at least one 
communication, and at least one behavioral), and onset before 36 months of age. A 
diagnosis of Asperger disorder specified qualitative impairments in social interaction and 
presence of restricted interests and repetitive behaviors, but no cognitive, language, or non-
social adaptive delays noted in early development. Diagnoses of PDD-NOS were described 
as a severe and pervasive impairment in the development of reciprocal social interaction 
associated with impairment in either verbal and nonverbal communication skills, or the 
presence of stereotyped behavior, interests, and activities, but criteria not met for another 
ASD. Children with PDD-NOS, therefore, had to meet at least two diagnostic criteria with 
one from the social domain. These criteria differed from those offered in DSM-IV in that 
social deficits were required to meet the DSM-IV-TR definition of ASD, but were not 
required to meet the DSM-IV definition of ASD, and ultimately improved diagnostic 
specificity [9, 10].
Despite an improvement in diagnostic specificity, children with ASD defined by DSM-IV-
TR criteria still presented with remarkable heterogeneity in symptom presentation defined 
by different levels of ASD severity and the presence of co-occurring conditions [11]. This 
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phenotypic diversity complicated diagnostic and treatment efforts, and the ability to 
synthesize findings from research studies [12]. In its publication of the DSM-5 in 2013, the 
APA made considerable changes to ASD diagnostic criteria in an effort to maintain 
diagnostic sensitivity and continue to improve diagnostic specificity. In DSM-5, ASD no 
longer includes subtypes but represents one singular condition defined by level of functional 
support required by the individual. DSM-5 also specifies that persons with ASD must meet 
all three social criteria (i.e., deficits in social-emotional reciprocity, deficits in nonverbal 
communicative behaviors, and deficits in developing, understanding, and maintaining 
relationships) and two of four behavioral criteria (i.e., repetitive speech or motor 
movements, insistence on sameness, restricted interests, or unusual response to sensory 
input) [1, 13].
The changes in DSM-5 diagnostic criteria have been thought to embody more restrictive 
requirements than the less stringent DSM-IV-TR PDD-NOS criteria with the potential to 
exclude very young children and those without intellectual disability (ID) [14–16]. 
Consequently, diagnostic sensitivity may suffer with improved diagnostic specificity and 
impact the early detection and treatment of children with ASD. Previous studies that 
compared the sensitivity and specificity of DSM-IV-TR to DSM-5 criteria utilized 
retrospective data collection methods and older populations of children (e.g., identifying 
DSM-5 symptoms in records of those evaluated with DSM-IV-TR criteria and employing a 
research algorithm applied to previously collected diagnostic instruments). To our 
knowledge, no study has examined concurrent coding of DSM-IV-TR and DSM-5 criteria 
for ASD by a clinician who evaluated the child at a developmental period when symptoms 
may be first recognized by a parent or healthcare professional.
The Study to Explore Early Development (SEED) is a multi-site case–control study 
designed to explore risk factors and behavioral phenotypes associated with ASD in children 
2–5 years of age [17]. In its second phase of data collection (SEED2), study clinicians were 
asked to complete DSM checklists for both DSM-IV-TR and DSM-5 criteria utilizing all 
available information on the child. The objectives of this analysis were to (1) report the 
sensitivity and specificity of DSM-IV-TR and DSM-5 definitions of ASD compared to 
SEED2 final classification criteria, (2) examine agreement between DSM-IV-TR and DSM-5 
definitions of ASD, and (3) evaluate differences between characteristics of children who met 
DSM-IV-TR but not DSM-5 definitions of ASD, and vice versa.
Methods
Participant ascertainment
SEED2 is a community-based case–control study conducted in six study sites across the 
United States: California, Colorado, Georgia, Maryland, North Carolina, and Pennsylvania. 
The SEED2 protocol was approved by Institutional Review Boards at each site and adhered 
to ethical standards. Children eligible for data collection were born between January 1, 2008 
and December 31, 2011, enrolled between 2 and 5 years of age, resided in one of the study 
areas, and lived with a knowledgeable caregiver who was competent to communicate in 
English (or in California and Colorado, in English or Spanish). Three groups of children 
were recruited from each site: (1) those with known ASD, (2) those with known 
Wiggins et al. Page 3
Soc Psychiatry Psychiatr Epidemiol. Author manuscript; available in PMC 2019 August 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
developmental delays (DD) identified from multiple educational and health providers or 
family or physician referral, and (3) those from the general population identified from state 
vital records. Children in the DD group were later defined as those with ASD symptoms 
(i.e., those who had ASD risk noted on an ASD screen, received an ASD evaluation, and did 
not meet study criteria for ASD) and those without ASD symptoms (i.e., those who did not 
have ASD risk noted on an ASD screen and, therefore, received a more limited evaluation). 
Families were highly diverse, including non-white minorities and low socioeconomic status 
families, with distributions comparable to the racial and ethnic diversity in the United States 
[18]. Caregivers of enrolled children gave written consent to participate in the study. A 
detailed description of eligibility criteria, ascertainment methods, enrollment methods, and 
data collection procedures can be found in Schendel et al. [17].
Data collection procedures
The Social Communication Questionnaire (SCQ) [19] was administered to all families to 
provide an initial assessment of ASD risk and determine assessment procedures. All children 
were given the Mullen Scales of Early Learning (MSEL) [20]; the MSEL Early Learning 
Composite score was used as a measure of ID. Families of children who obtained a score of 
11 or higher on the SCQ, had a previous ASD diagnosis, or demonstrated ASD behaviors 
during the MSEL administration were asked to complete the Autism Diagnostic Interview-
Revised (a comprehensive parent interview) (ADI-R) [21], Autism Diagnostic Observation 
Schedule (a standardized observation of the child) (ADOS) [22, 23], and Vineland Adaptive 
Behavior Scales-Second Edition (VABS-II) [24]. The ADOS and ADI-R are considered 
gold-standard diagnostic instruments used to differentiate children with ASD from children 
with other DD [25].
Clinicians who administered the ADOS and ADI-R had at least a Master’s degree in 
psychology or related field and were deemed field ready once they established 
administration fidelity and research reliability with a supervising clinician at their site. These 
clinicians were monitored by the supervising clinician for administration fidelity at least 
once per year and for coding reliability at least once per quarter (or every 10th ASD 
assessment). First-pass coding reliability for field clinicians was 92% for the ADOS and 
97% for the ADI-R. Supervising clinicians had a doctorate degree in psychology, medicine, 
or related field and established research reliability with a certified ADOS and ADI-R trainer. 
Supervising clinicians were monitored by each other for administration fidelity once during 
the study period and for coding reliability at least once per quarter. First-pass coding 
reliability for supervising clinicians also was 92% for the ADOS and 97% for the ADI-R.
DSM definitions
The clinician(s) who administered the ADOS and ADI-R completed two diagnostic 
checklists adapted for SEED2 from the Ohio State University (OSU) Autism Rating Scale 
[26]: one for DSM-IV-TR criteria and one for DSM-5 criteria. When completing the 
checklists, the clinician(s) was asked to rate each of the diagnostic criteria on the following 
scale: (0) never or rarely/not a problem, (1) sometimes/a little problem, (2) often/a pretty big 
problem, and (3) very often/a severe problem, given all available information on the child. 
Clinicians had access to information on ASD symptoms noted on the Social Responsiveness 
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Scale [27], behavior problems noted on the Child Behavior Checklist [28], and previously 
diagnosed conditions noted on a maternal interview, in addition to information collected 
with the ADI-R, ADOS, MSEL, VABS-II, and SCQ. Checklists were completed by both 
clinicians in collaboration when the ADOS and ADI-R were completed by two qualified 
staff members. Checklists were completed by one clinician when the ADOS and ADI-R 
were administered by the same person. The DSM-IV-TR checklist was administered before 
the DSM-5 checklist in the SEED2 study.
DSM-IV-TR autistic disorder was defined as the presence of at least six criteria (i.e., 
checklist ratings of ≥ 1) with two from the social domain, at least one from the 
communication domain, and at least one from the behavioral domain (Table 1). We 
considered a threshold of ≥ 1 for autistic disorder criteria because DSM-IV-TR denotes 
presence rather than severity of symptoms for diagnosis. A definition of Asperger disorder 
was not specified because only 30 children with ASD in the SEED2 sample did not have a 
cognitive or language delay noted on the MSEL and there were less than five of these 
children in some cells used to calculate sensitivity and specificity. Definitions of Childhood 
Disintegrative Disorder and Rett Syndrome were not created due to the low prevalence of 
these conditions. Two definitions of PDD-NOS were created for this analysis as indicated in 
the DSM-IV-TR:
• Impairment in any of the social criteria rated as (2) often/a pretty big problem or 
(3) very often/a severe problem AND impairment in any of the communication 
criteria rated as ≥ 1 (denoting “severe and pervasive impairment” in social skills 
and presence of communication deficits) (PDD-NOS(1)).
• Impairment in any of the social criteria rated as (2) often/a pretty big problem or 
(3) very often/a severe problem AND any of the behavioral criteria rated as ≥ 1 
(denoting “severe and pervasive impairment” in social skills and presence of 
restricted behavior, interests, or activities) (PDD-NOS(2)).
We did not create DSM-IV-TR PDD-NOS definitions independent of DSM-IV autistic 
disorder (i.e., the same child could meet all definitions). This method allowed assessment of 
clinical definitions independent of others with maximal sample size.
DSM-5 ASD was defined as the presence of all three social symptoms (i.e., ratings of ≥ 1) 
and two of four behavioral symptoms (Table 2). The clinician(s) who completed DSM-IV-
TR and DSM-5 checklists was also asked to rate severity of ASD symptoms (categorized for 
this analysis as mild, moderate, severe, or symptoms accounted for by another disorder), and 
certainty the child had ASD (categorized for this analysis as certain or uncertain).
ASD case status
SEED2 ASD case status was based on the results of the ADOS and ADI-R rather than a 
previous diagnosis or the diagnostic checklist. Briefly, children classified as ASD were those 
who met ASD criteria on both the ADI-R and ADOS, or who met ASD criteria on the 
ADOS and one of three alternate criteria on the ADI-R (i.e., met criteria on the social 
domain and was within two points on the communication domain, met criteria on the 
communication domain and was within two points on the social domain, or met criteria on 
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the social domain and had two points noted on the behavioral domain). Thus, if results of the 
ADOS and ADI-R were discrepant, the child could still be defined as an ASD case if ADOS 
criteria were met and one of the three alternate ADI-R criteria were met.
We recognize that diagnostic instruments alone cannot replace informed clinical judgment 
when diagnosing children with ASD. However, scores from the ADI-R and ADOS are both 
sensitive and specific in detecting children with ASD when used in combination, and offer 
several advantages to classify children with ASD in large epidemiologic studies. First, ADI-
R and ADOS scores are assigned by experienced and reliable clinicians and offer a uniform 
method of characterizing ASD symptoms in large cohorts of children that can be replicated 
in other studies. Second, symptom profiles gleaned from the ADI-R and ADOS allow the 
opportunity to create ASD sub-groups based on observed and/or reported symptoms that 
could represent a range of behavioral trajectories and phenotypes. Consequently, using the 
ADI-R and ADOS to classify children with ASD may be advantageous when well-defined 
groups of children are an important clinical or research outcome.
Previous analyses found that SEED final classification criteria had a good balance of 
sensitivity and specificity when compared to clinical judgment of whether the child had 
ASD or another DD, and support the use of these instruments when defining ASD case 
status in SEED [29]. Moreover, kappa agreement between SEED2 final classification status 
and clinical judgment was 0.71, reflecting substantial agreement. Details on the SEED final 
classification algorithm can be found in Wiggins et al. [29].
Statistical methods
Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) 
were assessed for the following ASD definitions compared to SEED2 final classification 
criteria as the gold-standard: DSM-5 ASD and DSM-IV-TR autistic disorder, PDD-NOS(1), 
PDD-NOS(2), and PDD-NOS(3). Sensitivity was the number of true positives (i.e., those 
defined as ASD by both the DSM checklist and SEED2 criteria) divided by the number of 
those defined as ASD by SEED2 criteria. Specificity was the number of true negatives (i.e., 
those defined as non-ASD by both the DSM checklist and SEED2 criteria) divided by the 
number of children defined as non-ASD based on SEED2 criteria. PPV was the number of 
true positives divided by the number of children who were defined as ASD by a DSM 
checklist definition; NPV was the number of true negatives divided by the number of 
children who were defined as non-ASD by a DSM checklist definition. The kappa statistic 
examined agreement between DSM-IV-TR and DSM-5 definitions of ASD, and chi square 
examined differences in characteristics of children who met DSM-IV-TR but not DSM-5 
definitions of ASD, and vice versa. Due to multiple comparisons, significance for p was set 
at 0.01.
Results
A total of 773 children met SEED2 criteria for ASD and 288 met criteria for another DD 
after a comprehensive evaluation. The study sample, therefore, consisted of those defined as 
ASD (n = 773) and those previously described as DD with ASD symptoms (n = 288). 
Children classified as ASD were more likely to be male (81% versus 65%; χ2 = 28.11, p < 
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0.01) and have ID (63% versus 33%; χ2 = 74.06, p < 0.01) than those with DD and ASD 
symptoms. Children classified as ASD and those classified as DD with ASD symptoms did 
not differ in terms of maternal ethnicity, maternal race, or child age at the time of clinic visit: 
15.8% of mothers identified as Hispanic, 51.8% of mothers identified as White, and the 
mean child age at the time of the clinic visit was 55 months (range 28–70 months).
Of the 1061 ASD and DD with ASD symptoms children in the sample, 802 met DSM-5 
ASD, 864 met DSM-IV-TR autistic disorder, 744 met PDD-NOS(1) and 736 met PDD-
NOS(2). Sensitivity, specificity, PPV, and NPV for each of these DSM definitions are shown 
in Table 3. DSM-5 ASD had a better balance of sensitivity and specificity compared to the 
SEED2 classification than DSM-IV-TR autistic disorder, PDD-NOS(1), or PDD-NOS(2).
There was substantial agreement between DSM-5 ASD and DSM-IV-TR autistic disorder [κ 
= 0.78 (95% CI 0.73–0.82)]. Agreement between DSM-5 ASD and DSM-IV-TR PDD-
NOS(1) and PDD-NOS(2) was moderate [κ = 0.57 (95% CI 0.54–0.60) and κ = 0.59 (95% 
CI 0.56–0.62), respectively].
There were 71 children who met DSM-IV-TR autistic disorder but not DSM-5 ASD and 66 
children who met DSM-IV-TR PDD-NOS(1) or DSM-IV-TR PDD-NOS(2) but not DSM-5 
ASD. Characteristics of these children compared to those who did not have conflicting 
DSM-IV-TR and DSM-5 definitions are shown in Table 4.
Of note, there were 9 children who met DSM-5 ASD but not DSM-IV-TR autistic disorder, 
and 120 children who met DSM-5 ASD, but not PDD-NOS(1) or PDD-NOS(2). Children 
who met DSM-5 ASD but not PDD-NOS(1) or PDD-NOS(2) were less likely to have 
intellectual disability (χ2 = 28.1, p < 0.01) and more likely to be female (χ2 = 8.5, p = 0.01) 
and have mild ASD symptoms (χ2 = 65.4, p < 0.01). There were no differences between 
children who met DSM-5 ASD but not PDD-NOS(1) or PDD-NOS(2) in terms of maternal 
ethnicity, maternal race, or clinician certainty the child had ASD.
Discussion
To our knowledge, this is the first study to compare concurrent coding of DSM-IV-TR and 
DSM-5 criteria for ASD by a research-reliable clinician who evaluated preschool children in 
multiple US communities. Results suggest that the DSM-5 definition of ASD maximizes 
diagnostic sensitivity and specificity in the SEED2 sample of young children. Moreover, 
agreement between DSM-5 and DSM-IV-TR definitions of ASD were good for autistic 
disorder and moderate for PDD-NOS. Children who met DSM-IV-TR autistic disorder, but 
not DSM-5 ASD were more likely to have mild ASD symptoms, or their symptoms were 
accounted for by another disorder. Children who met PDD-NOS but not DSM-5 ASD, or 
vice versa, were less likely to have ID and more likely to be female. These findings support 
the DSM-5 conceptualization of ASD in preschool children [30], and highlight the need to 
learn more about the developmental profile and service needs of females with ASD and 
those with milder symptoms.
Although ASD traits cluster among those diagnosed with ASD, specific ASD behaviors are 
distributed across the general population [31]. Consequently, creating boundaries for clinical 
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diagnosis or research classification inherently includes some children with ASD symptoms 
and excludes others with milder symptoms or subthreshold presentation. The goal of 
categorical diagnostic systems is to maximize diagnostic sensitivity (accurate inclusion of 
true positives) as well as diagnostic specificity (accurate exclusion of true negatives). Results 
presented herein suggest that DSM-5 criteria for ASD achieves this goal within a large 
community-based sample of preschool children. These results should be replicated in other 
large and geographically diverse samples that incorporate concurrent coding of DSM-IV-TR 
and DSM-5 criteria in a clinic setting.
Some children in the SEED2 sample had a developmental profile defined by mild ASD 
symptoms and symptoms that were better accounted for by another disorder. These children 
were more likely to meet DSM-IV-TR autistic disorder, but not DSM-5 ASD, or either of the 
DSM-IV-TR PDD-NOS definitions but not DSM-5 ASD. Additionally, children who met 
PDD-NOS(1) or PDD-NOS(2) but not DSM-5 ASD, or vice versa, were less likely to have 
ID and more likely to be female. These findings are strikingly similar to an analysis of 439 
children and adolescents enrolled in the Autism Treatment Network [30]. Previous SEED 
analyses have shown that children termed “DD with ASD symptoms” and used in these 
analyses have a phenotypic profile more similar to children with ASD than children with 
other DD [32]. These children may be those seen in clinic settings to differentiate from 
children with ASD, and likely face developmental challenges that warrant professional 
attention. Service delivery may, therefore, be more effective if based on the strengths and 
challenges of the individual child rather than inclusion in one categorical diagnosis. More 
research is needed on the developmental status of children with DD with ASD symptoms, 
and how they are recognized, diagnosed, and treated.
Less is known about the ASD phenotype of females compared to males with ASD [33]. 
Among females and males with similar ASD traits, females with more behavior problems or 
ID, or both, are more likely to be recognized and diagnosed [34, 35]. These results imply 
that higher-functioning females and those without ID may be missed by current diagnostic 
systems. Results of this study add to this dialogue by providing evidence that females who 
meet DSM-IV-TR autistic disorder are as likely as males to meet DSM-5 ASD; however, 
they are more likely than males to shift between DSM-IV-TR PDD-NOS and DSM-5 ASD.
DSM-IV-TR definitions of autistic disorder and PDD-NOS(1) and PDD-NOS(2) had an 
adequate balance of sensitivity and specificity. In fact, diagnostic specificity for PDD-
NOS(1) and PDD-NOS(2) was higher in these analyses than previous reports. One possible 
reason for the improvement in PDD-NOS specificity seen in this paper is that we considered 
severity rather than mere presence of social deficits in our PDD-NOS definition. If only 
presence of any of the social deficits were required, in addition to presence of any of the 
communication or behavioral deficits, specificity would have dropped from 0.75 to 0.06 for 
PDD-NOS(1) and 0.78 to 0.16 for PDD-NOS(2) (data not shown). Consequently, 
considering the severity of social deficits among those with subthreshold DSM-5 ASD 
presentation may help guide decisions to monitor the ASD symptoms over time, especially 
among females and those without ID.
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There are limitations associated with this study. First, evaluation instruments were 
administered in SEED2 as part of a research protocol so clinicians did not have a choice in 
the information collected to assess diagnostic symptoms. However, the instruments that were 
administered in SEED2 are considered gold-standard diagnostic instruments, and elicit valid 
and reliable information on ASD symptoms and other areas of development. Second, 
information collected during the child observation (ADOS) and parent interview (ADI-R) 
were considered in the diagnostic checklist, so the SEED final classification criteria and 
DSM definitions were not completely independent of one another. Nonetheless, this process 
reflects clinical practice and, therefore, may generalize to real-world clinic settings. Third, 
SEED2 did not systematically collect criteria for Social Communication Disorder (SCD), 
which was introduced in DSM-5 and thought to capture some children formerly defined as 
PDD-NOS. The closest definition of SCD in this study is PDD-NOS(1), which had an 
adequate balance of sensitivity and specificity for ASD classification. Fourth, the sample 
was limited to children 2–5 years of age who competed a comprehensive evaluation because 
of ASD risk noted on the SCQ. Sample characteristics undoubtedly influence measures of 
sensitivity and specificity so precaution must be taken when interpreting results. For 
instance, estimates of specificity (i.e., the number of true negatives) may have been reduced 
because only children with some social and communication difficulties—rather than 
children from the general population—were included the sample. Again, these sample 
characteristics may reflect clinical practice of distinguishing children with ASD from 
children with other DD, but must be considered nonetheless. In sum, these results are best 
generalized to samples with a similar age and developmental profile and may look different 
in sample of younger or older children or those with few social and communication 
concerns. Finally, this study was conducted many years after the publication of DSM-5 in 
2013 although it is novel in the approach and sample used to compare the sensitivity and 
specificity of DSM-IV-TR and DSM-5 definitions of ASD. The strengths of our analyses 
outweigh these limitations. This is the first study to present concurrent coding of DSM-IV-
TR and DSM-5 criteria for ASD by a clinician who evaluated preschool children with gold-
standard diagnostic instruments. The sample was large and ascertained from clinic and non-
clinic sources in multiple geographic areas throughout the United States. Results contribute 
to an important body of literature on how diagnostic criteria distinguish children with varied 
ASD symptoms, and highlights the need to learn more about those with mild ASD 
symptoms and the ASD phenotype in females. In conclusion, these findings support the 
DSM-5 conceptualization of ASD in preschool children and highlight areas for future 
research.
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Table 3
Psychometric properties of autism spectrum disorder criteria outlined in the Diagnostic and Statistical Manual 
of Mental Disorders (DSM) and defined in the Study to Explore Early Development-Phase 2 (SEED2)
SEED2 final classification
ASD DD
Meets DSM-5 ASDa 738 64 Sens = 0.95
Does not meet DSM-5 ASD 35 224 Spec = 0.78
PPV = 0.92
NPV = 0.86
Meets DSM-IV autistic disorderb 761 103 Sens = 0.98
Does not meet DSM-IV autistic disorder 12 185 Spec = 0.64
PPV = 0.88
NPV = 0.94
Meets DSM-IV-TR PDD-NOS(1)c 673 71 Sens = 0.87
Does not meet DSM-IV-TR PDD-NOS (1) 100 217 Spec = 0.75
PPV = 0.90
NPV = 0.68
Meets DSM-IV-TR PDD-NOS(2)d 673 63 Sens = 0.87
Does not meet DSM-IV-TR PDD-NOS(2) 100 225 Spec = 0.78
PPV = 0.91
NPV = 0.69
aAll three social symptoms and two of four behavioral symptoms in DSM-5
bAt least six of 12 total criteria with two from the social domain, at least one from the communication domain, and at least one from the behavioral 
domain in DSM-IV-TR
c
Impairment in any of the social criteria rated as a pretty big problem or severe problem AND presence of any of the communication criteria in 
DSM-IV-TR
d
Impairment in any of the social criteria rated as a pretty big problem or severe problem AND presence of any of the behavioral criteria in DSM-
IV-TR
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